These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 15919517)
41. Knockdown of fibronectin induces mitochondria-dependent apoptosis in rat mesangial cells. Wu D; Chen X; Guo D; Hong Q; Fu B; Ding R; Yu L; Hou K; Feng Z; Zhang X; Wang J J Am Soc Nephrol; 2005 Mar; 16(3):646-57. PubMed ID: 15677310 [TBL] [Abstract][Full Text] [Related]
42. Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis. Zhao X; Hao J; Duan H; Rong Z; Li F Exp Biol Med (Maywood); 2017 Jan; 242(2):160-168. PubMed ID: 27590500 [TBL] [Abstract][Full Text] [Related]
43. Inhibitory effect of cepharanthine on fibronectin production in growth factor-stimulated rat mesangial cells. Hayama M; Inoue R; Akiba S; Sato T Eur J Pharmacol; 2000 Feb; 390(1-2):37-42. PubMed ID: 10708704 [TBL] [Abstract][Full Text] [Related]
50. Heparins modulate extracellular matrix and protein synthesis of cultured rat mesangial cells. Wolthuis A; Boes A; Berden JH; Grond J Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(3):181-9. PubMed ID: 8097075 [TBL] [Abstract][Full Text] [Related]
51. Antiproliferative activity to glomerular mesangial cells and receptor binding of a heparin-mimicking polyaromatic anionic compound. Katz A; Vlodavsky I; Davies M; Miao HQ; Ben-Sasson SA; Darmon D; Hurwitz H; Borgel H; Benezra M J Am Soc Nephrol; 1997 Nov; 8(11):1688-97. PubMed ID: 9355071 [TBL] [Abstract][Full Text] [Related]
52. Effects of aldehyde-modified proteins on mesangial cell-matrix interaction. Hasegawa G; Nakano K; Tsutsumi Y; Kondo M Diabetes Res Clin Pract; 1994 Feb; 23(1):25-32. PubMed ID: 8013260 [TBL] [Abstract][Full Text] [Related]
53. Effect of rapamycin and FK506 on mesangial cell proliferation. Wang W; Chan YH; Lee W; Chan L Transplant Proc; 2001; 33(1-2):1036-7. PubMed ID: 11267180 [No Abstract] [Full Text] [Related]
54. [Interaction of cells and the extracellular matrix in the mesangium]. Mitrović S; Mitrović D; Marković-Lipkovski J Srp Arh Celok Lek; 2000; 128(1-2):34-41. PubMed ID: 10916462 [No Abstract] [Full Text] [Related]
55. Mechanical stress-cell function relationships in renal cells. Harris RC; Kondo S; Yasuda T Exp Nephrol; 1997; 5(4):263-70. PubMed ID: 9259179 [No Abstract] [Full Text] [Related]
57. Heparin, a possible therapy for diabetic complications: the effect on mesangial and myomedial cells in vivo and in vitro, especially in relation to extracellular matrix. Yokoyama H; Myrup B; Oturai P; Deckert T J Diabetes Complications; 1995; 9(2):97-103. PubMed ID: 7599355 [No Abstract] [Full Text] [Related]
58. Pathophysiological roles of gap junction in glomerular mesangial cells. Yao J; Zhu Y; Morioka T; Oite T; Kitamura M J Membr Biol; 2007 Jun; 217(1-3):123-30. PubMed ID: 17623230 [TBL] [Abstract][Full Text] [Related]
59. Differential effects of tautomycetin and its derivatives on protein phosphatase inhibition, immunosuppressive function and antitumor activity. Niu M; Sun Y; Liu B; Tang L; Qiu R Korean J Physiol Pharmacol; 2012 Apr; 16(2):145-51. PubMed ID: 22563261 [TBL] [Abstract][Full Text] [Related]
60. T Cell-specific immunosuppression using tautomycetin or PTD-conjugated protein drugs. Chae WJ; Choi JM; Yang JJ; Lee SK Yonsei Med J; 2004 Dec; 45(6):978-90. PubMed ID: 15627288 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]